Eckert & Ziegler SE

EUZ

DE0005659700

Office Equipment

Market Closed - Xetra Other stock markets 11:35:15 2024-06-28 EDT			5-day change	1st Jan Change
45.86 ^EUR	-4.22%		+1.91%	+11.04%

06-25	German Stocks Fall Tuesday	DJ
06-25	Eckert & Ziegler Unit Gets 'Encouraging' Feedback from US FDA for Lead Diagnostic	MT

Eckert & Ziegler Strahlen- Und Medizintechnik Ag Confirms Earnings Guidance for the Year 2023

October 17, 2023 at 10:58 am

Eckert & Ziegler Strahlen- und Medizintechnik AG confirmed earnings guidance for the year 2023. For the financial year 2023, the company expects sales of just under EUR 230 million. Profit of around EUR 25 million.

Latest news about Eckert & Ziegler SE

German Stocks Fall Tuesday	06-25	DJ
Eckert & Ziegler Unit Gets 'Encouraging' Feedback from US FDA for Lead Diagnostic	06-25	MT
Announcement drives Eckert & Ziegler - shares above 21-day line	06-25	DP
ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating	05-15	ZD
Eckert & Ziegler SE Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Transcript : Eckert & Ziegler SE, Q1 2024 Earnings Call, May 14, 2024	05-13
ECKERT & ZIEGLER : Hauck & Aufhauser maintains a Buy rating	04-24	ZD
Eckert & Ziegler increases profit at the start of the year - targets confirmed	04-22	DP
Eckert & Ziegler SE Reaffirms Earnings Guidance for the Year 2024	04-22	CI
RLS Radiopharmacies Partners with Eckert & Ziegler SE to Expand Production of Gallium-68-Based Radiopharmaceuticals	04-04	CI
Transcript : Eckert & Ziegler Strahlen- und Medizintechnik AG, 2023 Earnings Call, Mar 22, 2024	03-22
Eckert & Ziegler SE Reports Earnings Results for the Full Year Ended December 31, 2023	03-22	CI
Eckert & Ziegler recovers - Dividend disappointed - 'Balance sheet strong'	03-20	DP
Eckert & Ziegler cuts dividend in favor of investments	03-20	DP
ECKERT & ZIEGLER : Receives a Buy rating from Hauck & Aufhauser	03-20	ZD
Eckert & Ziegler plans further growth - dividend decreases significantly	03-19	DP
Eckert & Ziegler Strahlen- und Medizintechnik AG(XTRA:EUZ) added to Germany TECDAX Index (Price Return)	03-17	CI
Eckert & Ziegler Strahlen- und Medizintechnik AG(XTRA:EUZ) added to Germany TECDAX (Total Return) Index	03-17	CI
Deutsche Börse's Stoxx to Make Changes to DAX Indices	03-06	MT
Index changes move - MDax ejection weighs on Rational	03-06	DP
ECKERT & ZIEGLER : Gets a Buy rating from Hauck & Aufhauser	03-06	ZD
Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177	01-31	CI
ECKERT & ZIEGLER : Hauck & Aufhauser gives a Buy rating	01-03	ZD
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating	12-07	ZD
Chairman of the Supervisory Board of Eckert & Ziegler moves to subsidiary Pentixapharm	11-21	DP

Chart Eckert & Ziegler SE

Duration

Period

More charts

Company Profile

Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Sector

Office Equipment

Calendar

2024-08-09 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Eckert & Ziegler SE

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

45.86 EUR

Average target price

62.5 EUR

Spread / Average Target

+36.28%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Scientific & Precision Equipment

	1st Jan change	Capi.
ECKERT & ZIEGLER SE	+11.04%	1.02B
SHIMADZU CORPORATION	+2.11%	7.37B
TECAN GROUP AG	-12.41%	4.29B
OLINK HOLDING AB	+1.31%	3.18B
JEOL LTD.	+17.42%	2.31B
PARK SYSTEMS CORP.	+7.78%	941M
NINGBO YONGXIN OPTICS CO.,LTD	-39.11%	925M
MLOPTIC CORP.	-57.14%	676M
PHENIX OPTICAL COMPANY LIMITED	-28.72%	633M
FOCUSED PHOTONICS (HANGZHOU), INC.	-36.34%	623M

Scientific & Precision Equipment

Eckert & Ziegler SE

Equities

EUZ

DE0005659700

Office Equipment

Eckert & Ziegler Strahlen- Und Medizintechnik Ag Confirms Earnings Guidance for the Year 2023

Latest news about Eckert & Ziegler SE

Chart Eckert & Ziegler SE

Company Profile

Income Statement Evolution

Ratings for Eckert & Ziegler SE

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Scientific & Precision Equipment